Identification of colon adenocarcinoma necroptosis subtypes and tumor antigens for the development of mRNA vaccines

[1]  H. Xue,et al.  Reprogramming mitochondrial metabolism of macrophages by miRNA-released microporous coatings to prevent peri-implantitis , 2023, Journal of nanobiotechnology.

[2]  J. Liu,et al.  Recent advances in mRNA cancer vaccines: meeting challenges and embracing opportunities , 2023, Frontiers in immunology.

[3]  Cynthia Liu,et al.  Messenger RNA-Based Therapeutics and Vaccines: What’s beyond COVID-19? , 2023, ACS pharmacology & translational science.

[4]  Saad Abbas Abed,et al.  The Data-Driven Future of Healthcare: A Review , 2023, Mesopotamian Journal of Big Data.

[5]  D. Calvisi,et al.  Combination of AFP vaccine and immune checkpoint inhibitors slows hepatocellular carcinoma progression in preclinical models , 2023, The Journal of clinical investigation.

[6]  Lulu Wang,et al.  Increased SPRY1 expression activates NF-κB signaling and promotes pancreatic cancer progression by recruiting neutrophils and macrophages through CXCL12-CXCR4 axis , 2023, Cellular Oncology.

[7]  Jiaqian Wu,et al.  PRMT1 reverts the immune escape of necroptotic colon cancer through RIP3 methylation , 2023, Cell Death & Disease.

[8]  R. Taheri,et al.  An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations , 2023, International Immunopharmacology.

[9]  Wahid Khan,et al.  A Comprehensive Review of mRNA Vaccines , 2023, International journal of molecular sciences.

[10]  Yonglei Zhang,et al.  Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis , 2022, Frontiers in Immunology.

[11]  Xinxing Li,et al.  Bioinformatics analyses for the identification of tumor antigens and immune subtypes of gastric adenocarcinoma , 2022, Frontiers in Genetics.

[12]  Jinming Zhang,et al.  Prognostic necroptosis-related gene signature aids immunotherapy in lung adenocarcinoma , 2022, Frontiers in Genetics.

[13]  A. Xu,et al.  Identification of necroptosis-related genes for predicting prognosis and exploring immune infiltration landscape in colon adenocarcinoma , 2022, Frontiers in Oncology.

[14]  Tao Zhang,et al.  A necroptosis related prognostic model of pancreatic cancer based on single cell sequencing analysis and transcriptome analysis , 2022, Frontiers in Immunology.

[15]  I. Svane,et al.  Clinical advances and ongoing trials of mRNA vaccines for cancer treatment , 2022, The Lancet Oncology.

[16]  A. Batista-Duharte,et al.  Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches , 2022, Pharmaceutics.

[17]  M. Skwarczynski,et al.  The influence of component structural arrangement on peptide vaccine immunogenicity. , 2022, Biotechnology advances.

[18]  Hui-Ying Zhao,et al.  Wnt signaling in colorectal cancer: pathogenic role and therapeutic target , 2022, Molecular cancer.

[19]  Philipp Wolf,et al.  Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. , 2022, Biochimica et biophysica acta. Molecular cell research.

[20]  Z. Ding,et al.  Identifying tumor antigens and immuno‐subtyping in colon adenocarcinoma to facilitate the development of mRNA vaccine , 2022, Cancer medicine.

[21]  Sora Son,et al.  Development of mRNA Vaccines/Therapeutics and Their Delivery System , 2022, Molecules and cells.

[22]  Xiaonan Zheng,et al.  Tumor-antigens and immune landscapes identification for prostate adenocarcinoma mRNA vaccine , 2021, Molecular cancer.

[23]  P. Prieto,et al.  COVID-19 mRNA vaccine-related adenopathy mimicking metastatic melanoma , 2021, The Lancet Oncology.

[24]  A. Tafreshi,et al.  Five-Year Outcomes With Pembrolizumab Versus Chemotherapy for Metastatic Non–Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score ≥ 50% , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[25]  Leaf Huang,et al.  mRNA vaccine for cancer immunotherapy , 2021, Molecular cancer.

[26]  D. Schrag,et al.  Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review. , 2021, JAMA.

[27]  A. Jemal,et al.  Cancer Statistics, 2021 , 2021, CA: a cancer journal for clinicians.

[28]  M. Garcia-Buitrago,et al.  Molecular Insights Into Colorectal Carcinoma. , 2020, Archives of medical research.

[29]  F. Ghiringhelli,et al.  Interleukin-1β and Cancer , 2020, Cancers.

[30]  Brian Craft,et al.  Visualizing and interpreting cancer genomics data via the Xena platform , 2020, Nature Biotechnology.

[31]  Liu Cao,et al.  Septin4 promotes cell death in human colon cancer cells by interacting with BAX , 2020, International journal of biological sciences.

[32]  Wei Zhao,et al.  Intrinsic β-catenin signaling suppresses CD8+ T-cell infiltration in colorectal cancer. , 2019, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[33]  Minoru Kanehisa,et al.  New approach for understanding genome variations in KEGG , 2018, Nucleic Acids Res..

[34]  Chengqi Yi,et al.  Base-Resolution Mapping Reveals Distinct m1A Methylome in Nuclear- and Mitochondrial-Encoded Transcripts. , 2017, Molecular cell.

[35]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[36]  Minoru Kanehisa,et al.  KEGG: new perspectives on genomes, pathways, diseases and drugs , 2016, Nucleic Acids Res..

[37]  M. Bertrand,et al.  Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity. , 2016, Cell reports.

[38]  Etienne Becht,et al.  Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy , 2016, Clinical Cancer Research.

[39]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[40]  Paul Geeleher,et al.  pRRophetic: An R Package for Prediction of Clinical Chemotherapeutic Response from Tumor Gene Expression Levels , 2014, PloS one.

[41]  P. Kuppen,et al.  Combined analysis of HLA class I, HLA-E and HLA-G predicts prognosis in colon cancer patients , 2013, British Journal of Cancer.

[42]  Benjamin E. Gross,et al.  Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal , 2013, Science Signaling.

[43]  Justin Guinney,et al.  GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.

[44]  Sridhar Ramaswamy,et al.  Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..

[45]  Guangchuang Yu,et al.  clusterProfiler: an R package for comparing biological themes among gene clusters. , 2012, Omics : a journal of integrative biology.

[46]  C. Figdor,et al.  Immunogenicity of dendritic cells pulsed with CEA peptide or transfected with CEA mRNA for vaccination of colorectal cancer patients. , 2010, Anticancer research.

[47]  Matthew D. Wilkerson,et al.  ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking , 2010, Bioinform..

[48]  Guangchuang Yu,et al.  Gene Ontology Semantic Similarity Analysis Using GOSemSim. , 2020, Methods in molecular biology.

[49]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.